Cairo – Mubasher: Nile Co. for Pharmaceuticals and Chemical Industries (Nile Pharma) achieved net profits of EGP 18.71 million in the first quarter (Q1) of fiscal year (FY) 2021/2022, down by 16% year-on-year (YoY) from EGP 22.29 million, the unaudited financial results showed.
The revenues retreated to EGP 207.3 million in the July-September period, compared to EGP 218.42 million in the same period a year earlier, the company said in a bourse disclosure on Sunday.
During FY20/21, the pharmaceutical firm posted net profits of EGP 64.42 million, down from EGP 93.38 million in FY19/20.
